• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

测定糖尿病慢性肾脏病患者血清糖化白蛋白和高敏 C 反应蛋白对心血管并发症的认识。

Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.

机构信息

Kidney Care, C50, 10th B Cross, East Thillai Nagar, Tiruchirappalli-620 018, India.

Department of Medical Biochemistry, Division of Biomedical Sciences, School of Medicine, College of Health Sciences, Mekelle University (Ayder Campus), Mekelle, Ethiopia.

出版信息

Afr Health Sci. 2020 Mar;20(1):308-313. doi: 10.4314/ahs.v20i1.36.

DOI:10.4314/ahs.v20i1.36
PMID:33402919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7750066/
Abstract

BACKGROUND

Left ventricular hypertrophy (LVH) has been proved as one among the cardiovascular complications and predominant in patients with CKD. In CKD patients, Glycated albumin (GA) express a superior marker of glycemic control than HbA1c. Nevertheless, the precision of GA for the prediction of cardiovascular diseases among the CKD population has been ineffectively reported. The present study looks at the part of GA, HbA1c in CKD to envisage vascular complications.

MATERIALS AND METHODS

One hundred and ninety-four patients were selected in the present study. The study has a control group (Group I, N: 52) and participants were divided into two groups based on vein diseases (Group II, N: 42; two vessels and group III, N: 100; triple vessel disease). Serum glycated albumin, hsCRP and other routine parameters were estimated in all the three groups. 2-dimensional echocardiography (2D Echo) has been done by a cardiologist to all the study patients for assessing ejection fraction and distinguish the sort of vessel diseases.

RESULTS

Group I compared with group II and III shown there was a significant association among blood glucose, serum creatinine, HbA1c, mean blood glucose, GA, ejection fraction and hsCRP. Additionally, observed that increased levels of HbA1c, GA and creatinine inversely related to the left ventricle ejection fraction. Notwithstanding, GA and hsCRP predict precisely the left ventricle ejection fraction than different parameters.

CONCLUSION

GA alongside hsCRP might be appropriate markers for anticipating cardiovascular diseases particularly left ventricle hypertrophy in diabetic CKD population.

摘要

背景

左心室肥厚(LVH)已被证明是心血管并发症之一,在 CKD 患者中较为常见。在 CKD 患者中,糖基化白蛋白(GA)比 HbA1c 更能反映血糖控制情况。然而,GA 对 CKD 人群心血管疾病的预测准确性尚未得到有效报道。本研究旨在探讨 GA、HbA1c 在 CKD 患者中的作用,以预测血管并发症。

材料和方法

本研究纳入了 194 名患者。研究分为对照组(I 组,N=52)和实验组(根据静脉疾病分为 II 组,N=42;两血管疾病组和 III 组,N=100;三血管疾病组)。所有三组均检测血清 GA、hsCRP 和其他常规参数。由心脏病专家对所有研究患者进行二维超声心动图(2D 回声)检查,以评估射血分数并区分血管疾病类型。

结果

与 II 组和 III 组相比,I 组的血糖、血清肌酐、HbA1c、平均血糖、GA、射血分数和 hsCRP 之间存在显著相关性。此外,观察到 HbA1c、GA 和肌酐水平升高与左心室射血分数呈负相关。然而,GA 和 hsCRP 比其他参数更能准确预测左心室射血分数。

结论

GA 联合 hsCRP 可能是预测糖尿病 CKD 人群心血管疾病特别是左心室肥厚的合适标志物。

相似文献

1
Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients.测定糖尿病慢性肾脏病患者血清糖化白蛋白和高敏 C 反应蛋白对心血管并发症的认识。
Afr Health Sci. 2020 Mar;20(1):308-313. doi: 10.4314/ahs.v20i1.36.
2
Glycated albumin in diabetic patients with chronic kidney disease.糖尿病合并慢性肾脏病患者的糖化白蛋白。
Clin Chim Acta. 2012 Oct 9;413(19-20):1555-61. doi: 10.1016/j.cca.2012.04.025. Epub 2012 May 10.
3
The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.糖化白蛋白在糖尿病合并慢性肾脏病患者中的临床应用:进展与挑战。
J Diabetes Complications. 2018 Sep;32(9):876-884. doi: 10.1016/j.jdiacomp.2018.07.004. Epub 2018 Jul 11.
4
Relationship between the accuracy of glycemic markers and the chronic kidney disease stage in patients with type 2 diabetes mellitus.2型糖尿病患者血糖标志物准确性与慢性肾脏病分期之间的关系
Clin Nephrol. 2014 Aug;82(2):107-14. doi: 10.5414/CN108027.
5
Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population.糖化白蛋白与2型糖尿病患者慢性肾脏病风险:一项针对北印度人群的研究。
Diabetes Metab Syndr. 2018 May;12(3):381-385. doi: 10.1016/j.dsx.2018.01.005. Epub 2018 Jan 31.
6
Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.血清白蛋白校正糖化白蛋白反映了未接受透析治疗的重度慢性肾脏病糖尿病患者的血糖波动情况。
J Diabetes Complications. 2015 Sep-Oct;29(7):913-7. doi: 10.1016/j.jdiacomp.2015.06.003. Epub 2015 Jun 16.
7
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.使用连续血糖监测评估慢性肾脏病糖尿病患者的血糖控制标志物。
Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.
8
Glycated Albumin and Adverse Clinical Outcomes in Patients With CKD: A Prospective Cohort Study.糖化白蛋白与 CKD 患者不良临床结局的关系:一项前瞻性队列研究。
Am J Kidney Dis. 2024 Sep;84(3):329-338. doi: 10.1053/j.ajkd.2024.02.006. Epub 2024 Mar 20.
9
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.慢性肾脏病I - III期2型糖尿病患者肾功能对1,5 - 脱水葡萄糖醇血清浓度的影响:与糖化血红蛋白和糖化白蛋白的对比研究
J Diabetes. 2016 Sep;8(5):712-9. doi: 10.1111/1753-0407.12354. Epub 2016 Feb 3.
10
How does CKD affect HbA1c?CKD 如何影响 HbA1c?
J Diabetes. 2018 Apr;10(4):270. doi: 10.1111/1753-0407.12624. Epub 2017 Dec 21.

引用本文的文献

1
Hypersensitive C-reactive protein as a potential indicator for predicting left ventricular hypertrophy in elderly community-dwelling patients with hypertension.超敏 C 反应蛋白作为预测老年高血压社区居民左心室肥厚的潜在指标。
BMC Cardiovasc Disord. 2023 Sep 27;23(1):480. doi: 10.1186/s12872-023-03509-z.
2
Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects.白蛋白的整合作用:进化、生化及病理生理方面
J Evol Biochem Physiol. 2021;57(6):1419-1448. doi: 10.1134/S002209302106020X. Epub 2021 Dec 20.
3
Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties.血清白蛋白在健康和疾病中的作用:酯酶、抗氧化、转运和信号转导特性。
Int J Mol Sci. 2021 Sep 25;22(19):10318. doi: 10.3390/ijms221910318.
4
Reproductive health issues, infections and non-communicable diseases.生殖健康问题、感染与非传染性疾病。
Afr Health Sci. 2020 Mar;20(1):I-IV. doi: 10.4314/ahs.v20i1.1.

本文引用的文献

1
Glycated Albumin Predicts Long-term Survival in Patients Undergoing Hemodialysis.糖化白蛋白可预测接受血液透析患者的长期生存率。
Int J Med Sci. 2016 May 10;13(5):395-402. doi: 10.7150/ijms.14259. eCollection 2016.
2
Cardiovascular disease and its relationship with chronic kidney disease.心血管疾病及其与慢性肾脏病的关系。
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2918-26.
3
Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population?在慢性肾脏病患者中,有没有比糖化血红蛋白 A1c 更好的替代指标来评估血糖控制情况?
Nephrol Dial Transplant. 2014 Dec;29(12):2167-77. doi: 10.1093/ndt/gfu006. Epub 2014 Jan 26.
4
Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survival.糖化白蛋白可预测2型糖尿病血液透析患者的死亡风险:对改善生存率的目标水平的评估。
Ther Apher Dial. 2014 Oct;18(5):434-42. doi: 10.1111/1744-9987.12123. Epub 2013 Nov 20.
5
Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.慢性肾脏病患者左心室肥厚加重的危险因素。
Clin Exp Nephrol. 2013 Oct;17(5):730-742. doi: 10.1007/s10157-012-0758-4. Epub 2013 Jan 16.
6
Glycated albumin in diabetic patients with chronic kidney disease.糖尿病合并慢性肾脏病患者的糖化白蛋白。
Clin Chim Acta. 2012 Oct 9;413(19-20):1555-61. doi: 10.1016/j.cca.2012.04.025. Epub 2012 May 10.
7
Hypertension, left ventricular hypertrophy and chronic kidney disease.高血压、左心室肥厚和慢性肾脏病。
Heart Fail Rev. 2011 Nov;16(6):615-20. doi: 10.1007/s10741-010-9197-z.
8
Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test.基于空腹血糖和口服葡萄糖耐量试验,糖化白蛋白作为2型糖尿病血液透析患者血糖控制的改良指标。
Biomed Pharmacother. 2009 Mar;63(3):236-40. doi: 10.1016/j.biopha.2008.04.002. Epub 2008 May 15.
9
Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease.2型糖尿病终末期肾病患者血糖控制指标、心血管并发症与生存率之间的关联
Intern Med. 2007;46(12):807-14. doi: 10.2169/internalmedicine.46.6355. Epub 2007 Jun 15.
10
Left ventricular hypertrophy in nondiabetic predialysis CKD.非糖尿病透析前慢性肾脏病患者的左心室肥厚
Am J Kidney Dis. 2005 Aug;46(2):320-7. doi: 10.1053/j.ajkd.2005.04.031.